Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Will Linclon & Swartz also update holdings in earning report?eom.

Everything we learn in the report will be as of the end of Feb. There may be notes that are more current than that, but not a lot unless it comes in the form off a seperate PR. Should show Swartz holdings as of 2/28/08.

Corrections welcome.

Share
New Message
Please login to post a reply